AER under 314.80 (marketing applications) - quarterly reports

Postmarketing Adverse Drug Experience Reporting

⚠️ Notice: This form may be outdated. More recent filings and information on OMB 0910-0230 can be found here:

Document [html]

Download: html
Error

Sorry, the page you are looking for is currently unavailable.
Please try again later.

If you are the system administrator of this resource then you should check the error log for details.

Faithfully yours, nginx.